drugset / Trial / NCT04017442

Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery

NCT04017442

Phase 4 Completed 160 enrolled Icahn School of Medicine at Mount Sinai
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients presenting for normal spontaneous vaginal delivery who have a neuraxial anesthestic will be randomized to receive preservative free morphine or saline placebo after delivery.

Timeline

Start
2019-10-19
Primary completion
2023-08-31
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 2 mg Other